CRESCENT BIOPHARMA, INC. (CBIO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading CBIO…

CRESCENT BIOPHARMA, INC. (CBIO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

CRESCENT BIOPHARMA, INC.

CBIO · CIK 1253689

4 · Sep 18, 2026 · Chief Financial Officer Scalzo Richard William sold 568 shares at $17.90/share ($10,167)

4

Chief Financial Officer Scalzo Richard William sold 568 shares at $17.90/share ($10,167)

Filed: Sep 18, 2026
Period: Sep 16, 2026
Accession: 0001628280-26-062705
Filer: CRESCENT BIOPHARMA, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1789761760.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1789761760.xml
Open SEC.gov